Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

CTIP2 may help in skin development and maintenance.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

The AI showed high accuracy in diagnosing skin conditions but needs improvement for immunological and infectious disorders.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

TQC shows promise for better hair regrowth in treating hair loss.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Thymosin β4 helps improve skin healing and reduce scarring.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

A deep learning model was developed to help diagnose trichothiodystrophy by analyzing hair patterns.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Dermoscopy helps accurately diagnose temporal triangular alopecia, avoiding unnecessary treatments.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

TCM is an effective and safe treatment for primary cicatricial alopecias.

Trichoscopy is reliable for diagnosing Temporal Triangular Alopecia and can prevent unnecessary biopsies and wrong treatments.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

TBX3 gene affects pigmentation and marking formation in Dun Mongolian horses.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

TIP39 and PTH2R help control calcium levels and skin cell development.